Prediction of outcome in individuals with diabetic foot ulcers: Focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study

Diabetologia

Volumn 51, Issue 5, 2008, Pages 747-755

  Prompers, L ^a   Schaper, N ^a   Apelqvist, J ^b   Edmonds, M ^c   Jude, E ^d   Mauricio, D ^e   Uccioli, L ^f   Urbancic, V ^g   Bakker, K ^h   Holstein, P ⁱ   Jirkovska, A ^j   Piaggesi, A ^k   Ragnarson Tennvall, G ^l   Reike, H ^m   Spraul, M ⁿ   Van Acker, K ^o   Van Baal, J ^p   Van Merode, F ^q   Ferreira, I ^a   Huijberts, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MALMÖ UNIVERSITY   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d TAMESIDE GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^g UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^h International Working Group on the Diabetic Foot   (Netherlands)

ⁱ BISPEBJERG HOSPITAL   (Denmark)

^j INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^k UNIVERSITY HOSPITAL OF PISA   (Italy)

^l SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^m Mariannen Hospital   (Germany)

ⁿ Mathias Spital   (Germany)

^o St Joseph Clinic   (Belgium)

^p TWENTEBORG HOSPITAL   (Netherlands)

^q MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

Co morbidities; Diabetes; Foot ulcer; Infection; Non healing; Outcome; Peripheral arterial disease; Predictive model

Indexed keywords

ADULT; AGED; ARTERY DISEASE; ARTICLE; COHORT ANALYSIS; DIABETIC FOOT; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; ULCER HEALING;

AGE OF ONSET; AGED; DIABETIC ANGIOPATHIES; DIABETIC FOOT; FEMALE; FOOT ULCER; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; WOUND HEALING;

EID: 41849139963     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0940-0     Document Type: Article

References (40)

1. Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217-228
2. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, Willems J, Schaper NC (2005) Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia 48:1906-1910
3. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U (1995) Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 16:388-394
4. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J (1994) Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. J Intern Med 235:463-471
5. Ragnarson-Tennvall G, Apelqvist J (2004) Health-economic consequences of diabetic foot lesions. Clin Infect Dis 39(Suppl 2):S132-S139
6. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC (2000) International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 16(Suppl 1):S84-S92
7. Prompers L, Huijberts M, Apelqvist J et al (2007) High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale Study. Diabetologia 50:18-25
8. Boulton AJ (1996) The pathogenesis of diabetic foot problems: an overview. Diabet Med 13(Suppl 1):S12-S16
9. Armstrong DG, Lavery LA, Harkless LB (1998) Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21:855-859
10. Prompers L, Huijberts M, Apelqvist J et al (2007) Optimal organisation of health care in diabetic foot disease. Introduction to the Eurodiale Study. Int J Low Extrem Wounds 6:11-17
11. Schaper NC, Apelqvist J, Bakker K (2003) The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 3:475-479
12. Schaper NC (2004) Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 20(Suppl 1):S90-S95
13. Little R (1992) Regression with missing X's: a review. J Am Stat Assoc 87:1227-1237
14. Royston P (2005) Multiple imputation of missing values: update of ice. Stata Journal 5:527-536
15. van Buuren S, Boshuizen HC, Knook DL (1999) Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18:681-694
16. Rubin D (1987) Multiple imputation for nonresponse in surveys. Wiley, New York
17. Carlin J, Li N, Greenwood P, Coffey C (2003) Tools for analyzing multiple imputed datasets. Stata Journal 3:226-244
18. Jeffcoate WJ, Chipchase SY, Ince P, Game FL (2006) Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 29:1784-1787
19. Beckert S, Witte M, Wicke C, Konigsrainer A, Coerper S (2006) A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients. Diabetes Care 29:988-992
20. Oyibo SO, Jude EB, Tarawneh I et al (2001) The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 18:133-138
21. Cardoso CR, Salles GF (2007) Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients. Diabetes Res Clin Pract 75:51-58
22. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366:1695-1703
23. Harkless L, Boghossian J, Pollak R et al (2005) An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 6:27-40
24. Raymakers JT, Houben AJ, van der Heyden JJ, Tordoir JH, Kitslaar PJ, Schaper NC (2001) The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med 18:229-234
25. Morbach S, Quante C, Ochs HR, Gaschler F, Pallast JM, Knevels U (2001) Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis. Diabetes Care 24:1689-1690
26. Ince P, Kendrick D, Game F, Jeffcoate W (2007) The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes. Diabet Med 24:977-981
27. Miyajima S, Shirai A, Yamamoto S, Okada N, Matsushita T (2006) Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 71:272-279
28. Rajagopalan S, Dellegrottaglie S, Furniss AL et al (2006) Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114:1914-1922
29. Boufi M, Ghaffari P, Allaire E, Fessi H, Ronco P, Vayssairat M (2006) Foot gangrene in patients with end-stage renal disease: a case control study. Angiology 57:355-361
30. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H (2002) The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 40:472-479
31. Gensler SW, Haimovici H, Hoffert P, Steinman C, Beneventano TC (1965) Study of vascular lesions in diabetic, nondiabetic patients. Clinical, arteriographic, and surgical considerations. Arch Surg 91:617-622
32. Fejfarova V, Jirkovska A, Petkov V, Boucek P, Skibova J (2004) Comparison of microbial findings and resistance to antibiotics between transplant patients, patients on hemodialysis, and other patients with the diabetic foot. J Diabetes Complications 18:108-112
33. Cheung A, Wong L (2001) Surgical infections in patients with chronic renal failure. Infect Dis Clin North Am 15:775-796
34. Richards AM, Floyd DC, Terenghi G, McGrouther DA (1999) Cellular changes in denervated tissue during wound healing in a rat model. Br J Dermatol 140:1093-1099
35. Gibran NS, Jang YC, Isik FF et al (2002) Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 108:122-128
36. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA (2003) Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med 115:627-631
37. Armstrong DG, Lavery LA, Wu S, Boulton AJ (2005) Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 28:551-554
38. Mueller MJ, Diamond JE, Sinacore DR et al (1989) Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 12:384-388
39. Nabuurs-Franssen MH, Sleegers R, Huijberts MS et al (2005) Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 28:243-247
40. Nabuurs-Franssen MH, Huijberts MS, Sleegers R, Schaper NC (2005) Casting of recurrent diabetic foot ulcers: effective and safe? Diabetes Care 28:1493-1494